top of page
Medical Checkup

MOONSCAPE

Trial Enrolment Status

OPEN

Disease Under Study

Idiopathic Pulmonary Fibrosis

Duration

~52 Weeks + 52 Weeks OLE

About the Trial

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

Mechanism of Action:

Anti IL-31 and Anti Oncostatin M

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Cynthia Lee

bottom of page